UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 3, 2012
CEL-SCI CORPORATION
---------------------------------------
(Exact name of Registrant as specified in its charter)
Colorado 0-11503 84-0916344
---------------------------- ------------------------ ----------------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
8229 Boone Boulevard, Suite 802
Vienna, Virginia 22182
----------------------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (703) 506-9460
--------------
N/A
-------------------------------------------
(Former name or former address if changed since last report)
Item 8.01 Other Events
During the week ending February 3, 2012, CEL-SCI received $927,359 from the
exercise of series K warrants to purchase 3,091,195 shares of CEL-SCI's common
shares. These warrants were issued as part of the August 2006 financing, had an
exercise price of $0.30 and expired on February 4, 2012.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: February 6, 2011 CEL-SCI CORPORATION
By: /s/ Geert R. Kersten
-----------------------------------------
Geert R. Kersten, Chief Executive Officer
3
